Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Lawrence Corey and John Mascola.
Lawrence Corey
Connection Strength
0.493
John Mascola
  1. A strategic approach to COVID-19 vaccine R&D. Science. 2020 05 29; 368(6494):948-950.
    View in: PubMed
    Score: 0.220
  2. Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Stat Commun Infect Dis. 2017 Jan; 9(1).
    View in: PubMed
    Score: 0.180
  3. Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120. PLoS One. 2017; 12(11):e0185959.
    View in: PubMed
    Score: 0.046
  4. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. PLoS Med. 2017 Nov; 14(11):e1002435.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.